Showing 941-950 of 8790 results for "".
Highlighting the Role of the NP and PA: Insights from the Dermatology Education Foundation
https://practicaldermatology.com/topics/practice-management/highlighting-the-role-of-the-np-and-pa-insights-from-the-dermatology-education-foundation/20806/NPs and PAs ease the burden of an overwhelming demand for dermatologic care.FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-drug-prurigo-nodularis-long-term-use-dupilumab-examined/26925/In this week's DermwireTV, the FDA approves Galderma's Nemluvio for adults with prurigo nodularis; a study examines the long-term use of dupilumab for atopic dermatitis; and Andrew Mastro discusses how to talk to patients about starting a Janus kinase (JAK) inhibitor for AD.FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
https://practicaldermatology.com/series/dermwire-tv/fda-approves-axillary-hyperhidrosis-treatment-study-examines-biologic-outcomes-psoriasis/26562/In this week's DermwireTV, the FDA approves a first-of-its-kind gel for axillary hyperhidrosis; a new analysis examines how smoking, BMI, and age affect biologic outcomes in psoriasis; and the CEO of Aerolase joins us to discuss the latest trends in the aesthetic laser market.What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.The Use of Lasers and Energy-Based Devices in Patients with Richly Pigmented Skin
https://practicaldermatology.com/programs/practical-dermatology/the-use-of-lasers-and-energy-based-devices-in-patients-with-richly-pigmented-skin/18199/In the last of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Andrew Alexis, MD, a dermatologist from New York City and the President of the Skin of Color Society, Corey Hartman, MD, a dermatologist in Birmingham, Alabama, and Janiene Luke, MD, a dermatoloResidents' Report: Erythrodermic Psoriasis Post Radiation Treatment: A Case Presentation and Literature Review
https://practicaldermatology.com/topics/psoriasis/residents-report-erythrodermic-psoriasis-post-radiation-treatment-a-case-presentation-and-literature-review/21744/With limited coverage in the literature, erythrodermic psoriasis post radiation deserves further study.Time Is Hair: An Update on the Diagnosis and Treatment of Scarring Alopecias in Patients with Darker Skin Tones
https://practicaldermatology.com/programs/practical-dermatology/time-is-hair-an-update-on-the-diagnosis-and-treatment-of-scarring-alopecia-in-patients-with-darker-skin-tones/18198/In part two of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Dr. Andrew Alexis, a dermatologist from New York City and the President of the Skin of Color Society; Dr. Corey Hartman, a dermatologist in Birmingham, Alabama; and Dr. Janiene Luke, a dermatoloHow to Use ChatGPT to Create a Social Media Content Calendar for Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-use-chatgpt-to-create-a-social-media-content-calendar-for-your-practice/23968/ChatGPT can help you ideate content and post it with consistency.Treatment Considerations in the Short- and Long-Term Management of Plaque Psoriasis: Is There A Role for Tazarotene?
https://practicaldermatology.com/topics/psoriasis/treatment-considerations-in-the-shortandlong-term-management-of-plaquepsoriasis-is-there-a-role-for-tazarotene/23041/Tazarotene is almost a forgotten entity in management of psoriasis, despite quality data showing it can be both tolerable and effective—when used appropriately.Weighing the Role of Network Meta-analysis for Choosing Biologic Therapies in Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/weighing-the-role-of-network-meta-analysis-for-choosing-biologic-therapies-in-psoriatic-disease/18189/There’s no paucity of studies for biologic therapies used to treat psoriatic disease, but the number of head-to-head trials comparing these agents is limited. Enter network meta-analysis, a statistical methodology that has emerged over the past few years to compare medication. Philip Mease, MD, a cl